Ulrik Spork is director of SporCon Lifescience Advisors and Salient Pharma, and chairman of the boards of Dansk Vækstkapital, Practio, MedTrace, ROS-Therapeutics, SOBEC Emea and Technolution. In addition, he is a member of the board of Statumanu. For many years and up until 2015, Ulrik Spork was part of executive management in Novo Holdings and served as Head of Venture Investments, Senior Partner in Novo Ventures, Managing Partner in Novo Growth Equity and most recently Managing Partner for Large Investments. He was previously a board member and chairman of the Danish Venture Capital and Private Equity Association (DVCA). Ulrik brings to Reapplix substantial knowledge of financing and business development in life science companies.
Current role
Deputy Chairman at CitNOW Group
Managing Director And Deputy Chairman at Capital Agro for Import and Export (S.A.E)
Founder And Deputy Chairman at Reward
Deputy Chairman & Worldwide Co-Head of Editions at Phillips
CEO & Deputy Chairman at Brighton & Hove Albion FC
Access the worlds's biggest network of public org charts
Learn more